Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.
about
Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Tuftsin-based, EGFR-targeting ...... ted with CD47 down-regulation.
@en
type
label
Tuftsin-based, EGFR-targeting ...... ted with CD47 down-regulation.
@en
prefLabel
Tuftsin-based, EGFR-targeting ...... ted with CD47 down-regulation.
@en
P2093
P2860
P1476
Tuftsin-based, EGFR-targeting ...... ted with CD47 down-regulation.
@en
P2093
Sheng-Hua Zhang
Wen-Juan Liu
Xiu-Jun Liu
Yong-Su Zhen
P2860
P2888
P304
P356
10.1007/S00262-014-1604-1
P577
2014-08-28T00:00:00Z
P5875
P6179
1014752389